Rationale and Mechanisms of Cancer Chemoprevention
- 1 January 1999
- book chapter
- Published by Springer Nature
- Vol. 151, 29-44
- https://doi.org/10.1007/978-3-642-59945-3_3
Abstract
Chronic degenerative diseases, including cancer, have a multifactorial origin. An intricate network connects each disease with multiple risk factors and also with multiple protective factors. From the point of view of preventive medicine, this implies that removal of a single risk factor will have a beneficial impact on the epidemiology of several diseases. However, in contrast to the situation in infectious diseases, it will never be possible to eradicate any chronic degenerative disease in this way, because each of them is associated with other risk factors at the same time. Similarly, a single protective factor can decrease the risk of contracting different diseases, and the risk of developing a single disease can be attenuated by different protective factors, often in a coordinated fashion. It is thus evident that cancer can be prevented not only by avoiding exposure to recognized risk factors, but also, as a complementary approach referred to as chemoprevention, by favouring the intake of protective factors and by fortifying the physiological defences of the host organism. Chemoprevention can be applied in a primary prevention setting when it is addressed to healthy individuals with the goal of inhibiting occurrence of the disease. Conversely, it is applied in a secondary prevention setting when it is addressed to individuals affected by premalignant tumours, with the goal of reversing the carcinogenesis process. A rational use of chemopreventive agents is based not only on the assessment of their efficacy and safety but also on understanding of their mechanisms of action. A detailed classification is proposed, which covers a variety of mechanisms interfering with different phases of mutagenesis and carcinogenesis. However, this sequence of events does not fit in with a rigid scheme, and several mechanisms, such as inhibition of genotoxic effects, antioxidant activity and scavenging of free radicals, inhibition of cell proliferation, and signal transduction modulation are reiterated several times throughout evolution of these processes. Some of these mechanisms are also involved in advanced stages of tumour progression towards malignancy, invasion and metastasis, and can therefore conveniently be applied for the tertiary prevention of cancer. Most inhibitors work through multiple mechanisms, examples of which are given for 18 chemopreventive agents.Keywords
This publication has 38 references indexed in Scilit:
- Inhibition of rat liver cytochrome P450 isozymes by isothiocyanates and their conjugates: a structure-activity relationship studyCarcinogenesis: Integrative Cancer Research, 1996
- Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell linesNutrition and Cancer, 1996
- Retinoids and chemoprevention: Clinical and basic studiesJournal of Cellular Biochemistry, 1995
- Chemopreventive properties and mechanisms ofN-acetylcysteine. The experimental backgroundJournal of Cellular Biochemistry, 1995
- Oltipraz: Clinical opportunities for cancer chemopreventionJournal of Cellular Biochemistry, 1995
- Mechanisms of the in vitro antimutagenic action of chlorophyllin against benzo[a]pyrene: Studies of enzyme inhibition, molecular complex formation and degradation of the ultimate carcinogenMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1994
- Cancer prevention strategies and mechanisms of chemopreventive agentsEuropean Journal Of Cancer Prevention, 1994
- Assessment of antimutagenicity and anticarcinogenicityMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1992
- Strategies for inhibiting multistage carcinogenesis based on signal transduction pathwaysMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
- An integrative hypothesis linking cancer, diabetes and atherosclerosis: The role of mutations and epigenetic changesMedical Hypotheses, 1980